Veristat Strengthens Statistical Consulting and Adaptive Design Trial Expertise With...
Appoints Mark Chang as Senior Vice President of Strategic Statistical Consulting
SOUTHBOROUGH, MA – June 15, 2016 – Veristat, a full...
Veristat Expands Its Clinical Operations into Europe - Acquires UK-based CRO, Spero Oncology
SOUTHBOROUGH, MA – May 2, 2016 – Veristat, a full service Clinical Research Organization (CRO), announced today that it is expanding its...
Veristat Ranked #35 on Boston Business Journal’s “Fast 50” List, the Top 50 Fastest Growing...
Veristat Recognized as One of the Top 50 Fastest-Growing Private Companies in Massachusetts
Veristat, a full service Clinical Research...
Veristat Named as One of the Fastest Growing Private Companies in Massachusetts by Boston...
Veristat joins the Boston Business Journal’s 2016 Fast 50 (Formerly Pacesetters) list. This is the list of the fastest growing private...
Veristat Strengthens Senior Management Team: Appoints Faith Haines Kolb as Vice President,...
SOUTHBOROUGH, MA – March 08, 2016 – Veristat, a full service Clinical Research Organization (CRO), announced today the appointment of Faith...
Veristat participates in Cycle for Survival 2016 and raises over $20,000 to fund rare...
Veristat Raises over $20,000 to Support Rare Cancer Research
On Saturday, February 27th, Team Veristat JOINED THE BATTLE with Cycle for...
Veristat Rides in Cycle for Survival 2016 Event to Raise Money to Fight Rare Cancers
Veristat Supports the Upcoming Boston Cycle for Survival Event Join Veristat in the Fight Against Rare Cancers: Donate Today!
Veristat and Cidara Therapeutics Collaborate with a Preferred Provider Agreement
Veristat to Assist Cidara with Its Trials for Novel Echinocandin Antifungal CD101